|
ZNF564 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.42959999999992E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.777520E-04 |
| Normal-vs-Stage2 |
9.723600E-03 |
| Normal-vs-Stage3 |
1.85879999999861E-05 |
| Normal-vs-Stage4 |
2.43070000016665E-07 |
| Stage1-vs-Stage2 |
2.963400E-01 |
| Stage1-vs-Stage3 |
1.376990E-01 |
| Stage1-vs-Stage4 |
5.204700E-03 |
| Stage2-vs-Stage3 |
4.615700E-02 |
| Stage2-vs-Stage4 |
2.235200E-03 |
| Stage3-vs-Stage4 |
1.048960E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.72279999999247E-05 |
| Normal-vs-AfricanAmerican |
3.514000E-02 |
| Normal-vs-Asian |
1.200670E-03 |
| Caucasian-vs-AfricanAmerican |
2.104400E-01 |
| Caucasian-vs-Asian |
2.214800E-01 |
| AfricanAmerican-vs-Asian |
7.393600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.195100E-04 |
| Normal-vs-Female |
4.00630000000346E-05 |
| Male-vs-Female |
5.394000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.426450E-04 |
| Normal-vs-Age(41-60Yrs) |
1.156960E-04 |
| Normal-vs-Age(61-80Yrs) |
6.03169999999764E-05 |
| Normal-vs-Age(81-100Yrs) |
5.653900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.676600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.710400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.943000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.760200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.540200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.126600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.554300E-04 |
| Classical-VS-Follicular |
1.534030E-01 |
| Classical-VS-Other |
7.811200E-01 |
| Classical-VS-Normal |
1.350600E-04 |
| Tall-VS-Follicular |
5.88059999999668E-05 |
| Tall-VS-Other |
4.995000E-01 |
| Tall-VS-Normal |
3.99809999551692E-08 |
| Follicular-VS-Other |
4.297200E-01 |
| Follicular-VS-Normal |
5.862700E-03 |
| Other-VS-Normal |
7.598100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.966900E-04 |
| Normal-vs-N1 |
7.16629999786278E-08 |
| N0-vs-N1 |
2.759500E-04 |
|
|
